Login / Signup
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro.
Kyung Soo Hong
June Hong Ahn
Jong Geol Jang
Jong Ho Lee
Hong Nam Kim
Dongha Kim
Wonhwa Lee
Published in:
Signal transduction and targeted therapy (2020)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus
signaling pathway
pi k akt
coronavirus disease
cell proliferation